![Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain - ScienceDirect Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0028390817305142-fx1.jpg)
Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain - ScienceDirect
![Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain | Molecular Psychiatry Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain | Molecular Psychiatry](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmp.2009.62/MediaObjects/41380_2009_Article_BFmp200962_Fig1_HTML.jpg)
Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain | Molecular Psychiatry
Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes | ACS Pharmacology & Translational Science
![Receptors | Free Full-Text | Pharmacology of Minor Cannabinoids at the Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by Tetrahydrocannabivarin Receptors | Free Full-Text | Pharmacology of Minor Cannabinoids at the Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by Tetrahydrocannabivarin](https://www.mdpi.com/receptors/receptors-01-00002/article_deploy/html/images/receptors-01-00002-g001.png)
Receptors | Free Full-Text | Pharmacology of Minor Cannabinoids at the Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by Tetrahydrocannabivarin
![Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical](https://cdn2.caymanchem.com/cdn/cms/caymanchem/PublishingImages/Lists/NewsItems/AllItems/cannabinoid%20signaling%20figure%201.png)
Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical
![The effect of cannabinoid receptor agonist WIN 55,212–2 on anxiety‐like behavior and locomotion in a genetic model of absence seizures in the elevated plus‐maze - Cassar - 2022 - CNS Neuroscience & The effect of cannabinoid receptor agonist WIN 55,212–2 on anxiety‐like behavior and locomotion in a genetic model of absence seizures in the elevated plus‐maze - Cassar - 2022 - CNS Neuroscience &](https://onlinelibrary.wiley.com/cms/asset/944d0127-7289-44d4-b51d-d149bc6fb6da/cns13848-toc-0001-m.png)
The effect of cannabinoid receptor agonist WIN 55,212–2 on anxiety‐like behavior and locomotion in a genetic model of absence seizures in the elevated plus‐maze - Cassar - 2022 - CNS Neuroscience &
![Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1 Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1](https://www.spandidos-publications.com/article_images/mmr/13/6/MMR-13-06-4569-g02.jpg)
Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1
![The structure of synthetic cannabinoid agonists WIN 55,212-2 (WIN).... | Download Scientific Diagram The structure of synthetic cannabinoid agonists WIN 55,212-2 (WIN).... | Download Scientific Diagram](https://www.researchgate.net/publication/286993189/figure/fig1/AS:621213151932416@1525120165303/The-structure-of-synthetic-cannabinoid-agonists-WIN-55-212-2-WIN-Molecular-formula.png)
The structure of synthetic cannabinoid agonists WIN 55,212-2 (WIN).... | Download Scientific Diagram
![Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical](https://cdn2.caymanchem.com/cdn/cms/caymanchem/PublishingImages/Lists/NewsItems/AllItems/cannabinoid%20signaling%20figure%202.png)
Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical
![The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines | Anticancer Research The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/37/11/6341/F1.large.jpg)
The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines | Anticancer Research
4 Dose-dependent induction of cannabinoid tetrad effects by the SCB WIN... | Download Scientific Diagram
![Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1 Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1](https://www.spandidos-publications.com/article_images/mmr/13/6/MMR-13-06-4569-g05.jpg)
Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1
![Regional Differences in Cannabinoid Receptor/G-protein Coupling in Rat Brain | Journal of Pharmacology and Experimental Therapeutics Regional Differences in Cannabinoid Receptor/G-protein Coupling in Rat Brain | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/282/3/1632/F3.large.jpg)
Regional Differences in Cannabinoid Receptor/G-protein Coupling in Rat Brain | Journal of Pharmacology and Experimental Therapeutics
![WIN55,212-2 (WIN), a cannabinoid receptor agonist, suppresses EPSCs... | Download Scientific Diagram WIN55,212-2 (WIN), a cannabinoid receptor agonist, suppresses EPSCs... | Download Scientific Diagram](https://www.researchgate.net/profile/Dale-Fortin/publication/7306030/figure/fig7/AS:668548166873097@1536405712775/WIN55-212-2-WIN-a-cannabinoid-receptor-agonist-suppresses-EPSCs-evoked-from-layer-5.png)
WIN55,212-2 (WIN), a cannabinoid receptor agonist, suppresses EPSCs... | Download Scientific Diagram
![Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212‐2 alters migration of early‐born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex - Saez - 2014 - Journal Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212‐2 alters migration of early‐born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex - Saez - 2014 - Journal](https://onlinelibrary.wiley.com/cms/asset/98a14448-2697-442d-a2ff-a3f261e97c7e/jnc12636-fig-0008-m.jpg)